ACAD

Acadia Remains On Track With Pimavanserin Program

moreView todays social media effects on ACADView the latest stocks trending across Twitter. Click to view dashboardSee who ACADIA is hiring next, click here to view […]

ACADIA Pharmaceuticals’ (ACAD) CEO Uli Hacksell on Q1 2014 Results – Earnings Call Transcript

[at Seeking Alpha] – Uli Hacksell Thank you, Lisa, and good afternoon. Let me first take this opportunity to thank all of you for joining us on today’s conference call. The first quarter of 2014 was another decent productive … moreView todays social media effects on ACADView the latest stocks trending across Twitter. Click to view dashboardSee who ACADIA is […]

ACADIA Pharmaceuticals Reports First Quarter 2014 Financial Results

[Business Wire] – ACADIA Pharmaceuticals Inc. , a biopharmaceutical company focused on the development and commercialization of innovative medicines that address unmet medical needs in moreView todays social media effects on ACADView the latest stocks trending across Twitter. Click to view dashboardSee who ACADIA is hiring next, click here to view […]

Backtesting A Value Strategy

moreView todays social media effects on ACADView the latest stocks trending across Twitter. Click to view dashboardSee who ACADIA is hiring next, click here to view […]

ACADIA Pharmaceuticals Prices Public Offering of Common Stock

[Business Wire] – ACADIA Pharmaceuticals Inc. today announced the pricing of an underwritten public offering of 6,400,000 shares of its common stock, offered at a price to the public of $28.50 per share. moreView todays social media effects on ACADView the latest stocks trending across Twitter. Click to view dashboardSee who ACADIA is hiring next, click here to view […]